The Jastreboff trial demonstrated a 42% relative reduction in hepatic fat content (MRI-PDFF measured) in the 8mg and 12mg retatrutide arms versus 2% with placeboa magnitude not seen with semaglutide or tirzepatide monotherapy in comparable populations
GLP-1, or glucagon-like peptide-1, is a hormone that regulates blood sugar levels and appetite
Important medical disclaimer This page is for general information only and does not constitute medical advice, diagnosis, or treatment
The trial concluded that the medication supported substantial and sustained weight loss, as quoted from the study findings, when combined with lifestyle changes
[1] Side Effects of Compounded* Semaglutide Nausea, vomiting, diarrhoea, constipation and stomach pain are the most common side effects of GLP-1 medications